Skip header and navigation

Refine By

   MORE

13 records – page 1 of 2.

Antibody to HIV in patients with acute hepatitis B in the period 1975-1984.

https://arctichealth.org/en/permalink/ahliterature8746
Source
Scand J Infect Dis. 1987;19(2):167-72
Publication Type
Article
Date
1987
Author
M. Arendrup
B O Lindhardt
K. Krogsgaard
J. Gaub
J O Nielsen
Source
Scand J Infect Dis. 1987;19(2):167-72
Date
1987
Language
English
Publication Type
Article
Keywords
Acquired Immunodeficiency Syndrome - complications - epidemiology - immunology
Acute Disease
Adult
Antibodies, Viral - analysis
Denmark
Female
Follow-Up Studies
HIV - immunology
HIV Antibodies
Hepatitis B - complications - immunology
Humans
Immunity, Cellular
Male
Retrospective Studies
Time Factors
Abstract
In order to elucidate the time when HIV was introduced into a population of patients with acute hepatitis B, serum samples collected in the period 1975-1984 from 331 patients with hepatitis B were analysed for the presence of antibody to HIV (anti-HIV). Anti-HIV was not detected in any of the serum samples from 97 females. 5/234 serum samples from males (2%) were repeatedly positive. Anti-HIV was first demonstrated in 1978, 3 years before the first patients with AIDS were recognized in Denmark. None of the 4 Danish patients with anti-HIV developed AIDS during a follow-up period of 1-7 years. However, at the time of follow-up in 1985 3 had decreased cell mediated immunity. The hepatitis B infection had an uncomplicated course in 4/5 patients with anti-HIV. One patient had a protracted delta hepatitis and was a HBsAg carrier before as well as after the acute hepatitis. Thus, the HIV infection did not cause any complicated course in this study.
PubMed ID
3475776 View in PubMed
Less detail

Clinical course of primary HIV infection: consequences for subsequent course of infection.

https://arctichealth.org/en/permalink/ahliterature8470
Source
BMJ. 1989 Jul 15;299(6692):154-7
Publication Type
Article
Date
Jul-15-1989
Author
C. Pedersen
B O Lindhardt
B L Jensen
E. Lauritzen
J. Gerstoft
E. Dickmeiss
J. Gaub
E. Scheibel
T. Karlsmark
Author Affiliation
Department of Infectious Diseases, Hvidovre Hospital, Denmark.
Source
BMJ. 1989 Jul 15;299(6692):154-7
Date
Jul-15-1989
Language
English
Publication Type
Article
Keywords
Acquired Immunodeficiency Syndrome - complications - immunology
Adolescent
Adult
CD4-Positive T-Lymphocytes - classification
Denmark
HIV Antigens - analysis
HIV Seropositivity - complications - immunology
Humans
Male
Middle Aged
Opportunistic Infections - complications
Prospective Studies
Research Support, Non-U.S. Gov't
Time Factors
Abstract
OBJECTIVE--To investigate the impact of the clinical course of the primary HIV infection on the subsequent course of the infection. DESIGN--Prospective documenting of seroconversion, follow up at six month intervals, and analysis of disease progression by life tables. PATIENTS--86 Men in whom seroconversion occurred within 12 months. PRIMARY OUTCOME MEASURE--Progression of HIV infection, defined as CD4 lymphocyte count less than 0.5 X 10(9)/l, recurrence of HIV antigenaemia, or progression to Centers for Disease Control group IV. MAIN RESULTS--Median follow up was 670 (range 45-1506) days. An acute illness like glandular fever occurred in 46 (53%) subjects. Three year progression rates to Centers for Disease Control group IV was 78% at three years for those who had longlasting illnesses (duration greater than or equal to 14 days) during seroconversion as compared with 10% for those who were free of symptoms or had mild illness. All six patients who developed AIDS had had longlasting primary illnesses. Three year progression rates to a CD4 lymphocyte count less than 0.5 X 10(9)/l and to recurrence of HIV antigenaemia were significantly higher for those who had longlasting primary illnesses than those who had no symptoms or mild illness (75% v 42% and 55% v 14%, respectively). CONCLUSION--The course of primary infection may determine the subsequent course of the infection.
PubMed ID
2569901 View in PubMed
Less detail

[Danger of infection by exposure to blood--risk for hospital personnel].

https://arctichealth.org/en/permalink/ahliterature212356
Source
Ugeskr Laeger. 1996 Mar 25;158(13):1803
Publication Type
Article
Date
Mar-25-1996

The development of AIDS or AIDS-related conditions in a cohort of HIV antibody-positive homosexual men during a 3-year follow-up period.

https://arctichealth.org/en/permalink/ahliterature8477
Source
J Intern Med. 1989 Jun;225(6):403-9
Publication Type
Article
Date
Jun-1989
Author
C. Pedersen
P. Kolby
J. Sindrup
J. Gaub
S. Ullman
J. Gerstoft
B O Lindhardt
E. Dickmeiss
Author Affiliation
Department of Infectious Diseases, Hvidovre Hospital, Denmark.
Source
J Intern Med. 1989 Jun;225(6):403-9
Date
Jun-1989
Language
English
Publication Type
Article
Keywords
AIDS-Related Complex - epidemiology
Acquired Immunodeficiency Syndrome - epidemiology - etiology
Adult
Antigens, Differentiation, T-Lymphocyte
Denmark
Follow-Up Studies
HIV Seropositivity - epidemiology
Homosexuality
Humans
Lymphocytes - immunology
Male
Prospective Studies
Research Support, Non-U.S. Gov't
Abstract
One hundred and thirty-three homosexual men seropositive for the antibody against human immunodeficiency virus (HIV) were enrolled in a prospective study in 1984-85. The 3-year cumulative incidences of the acquired immunodeficiency syndrome (AIDS) and AIDS-related conditions, by life-table analyses, were 18% and 34%. The cumulative incidence of immune deficiency defined as CD4 lymphocytes less than 0.5 x 10(9) l-1 was 70% at 3 years. Absence of antibodies to p24 antigen, HIV antigenaemia, CD4 lymphocytes less than 0.3 x 10 l-1 and elevated serum level of IgA were significantly associated with the development of AIDS. There was no association between disease progression and persistent generalized lymphadenopathy. When adjusted to the probable year of infection, these results are in accordance with previous cohort studies. It is concluded that most, or all, subjects seropositive for HIV will develop progressive loss of CD4 lymphocytes followed by clinical signs of immune deficiency, and that differences among previous cohorts with respect to disease progression are probably due to differences in the duration of infection.
PubMed ID
2787377 View in PubMed
Less detail

[Epidemic hepatitis following consumption of imported oysters]

https://arctichealth.org/en/permalink/ahliterature57131
Source
Ugeskr Laeger. 1973 Feb 12;135(7):345-8
Publication Type
Article
Date
Feb-12-1973

[Hepatitis epidemic among drug addicts in Esbjerg from July 1993 to May 1994]

https://arctichealth.org/en/permalink/ahliterature7859
Source
Ugeskr Laeger. 1995 Oct 9;157(41):5701-3
Publication Type
Article
Date
Oct-9-1995
Author
J C Hedberg
J. Gaub
Author Affiliation
Medicinsk afdeling, Centralsygehuset i Esbjerg.
Source
Ugeskr Laeger. 1995 Oct 9;157(41):5701-3
Date
Oct-9-1995
Language
Danish
Publication Type
Article
Keywords
Adolescent
Adult
Denmark - epidemiology
Disease Outbreaks
English Abstract
Female
Hepatitis A - epidemiology - transmission
Hepatitis B - epidemiology - transmission
Hepatitis C - epidemiology - transmission
Humans
Male
Retrospective Studies
Socioeconomic Factors
Substance Abuse, Intravenous - complications
Abstract
During 11 months from July 1993 to May 1994 the Department of Internal Medicine at Esbjerg Centralsygehus saw 19 patients with acute hepatitis A, B and/or C. In a normal year one to three patients are admitted with acute viral hepatitis. Sixteen of the patients reported intravenous drug use, half of them only sporadically, i.e. once or twice a month. Acute hepatitis A, B and C were seen in seven different combinations, the most frequent being acute hepatitis B in a hepatitis C antibody positive patient. The occurrence of acute hepatitis A in this group of patients may be due to parenteral transmission. Among 10 patients tested for HIV antibodies, none were found to be positive. In Esbjerg, which is the fifth largest city in Denmark, an automat with clean needles and syringes was installed six months after the culmination of the epidemic.
PubMed ID
7571105 View in PubMed
Less detail

[LAV/HTLV III antibody in patients with acute hepatitis B 1975-1984]

https://arctichealth.org/en/permalink/ahliterature56945
Source
Ugeskr Laeger. 1986 Mar 31;148(14):825-8
Publication Type
Article
Date
Mar-31-1986

[LAV/HTLV III infection in a group of homosexual and bisexual men in 1983 and 1985]

https://arctichealth.org/en/permalink/ahliterature8768
Source
Ugeskr Laeger. 1986 Mar 31;148(14):863-5
Publication Type
Article
Date
Mar-31-1986

The LAV/HTLV-III screening in Copenhagen. Epidemiological results from four clinics over the period 1 July 1984 to 1 April 1985.

https://arctichealth.org/en/permalink/ahliterature8755
Source
Dan Med Bull. 1986 Oct;33(5):268-70
Publication Type
Article
Date
Oct-1986
Author
P. Kolby
C. Pedersen
J H Sindrup
J. Gaub
M. Arendrup
J. Gerstoft
Source
Dan Med Bull. 1986 Oct;33(5):268-70
Date
Oct-1986
Language
English
Publication Type
Article
Keywords
Acquired Immunodeficiency Syndrome - epidemiology
Denmark
Female
Homosexuality
Humans
Male
Mass Screening
Abstract
Over the nine month period from 1st July 1984 to 1st April 1985, 737 persons attended the four AIDS-screening clinics in Copenhagen. The attendance was unconditional, and the examination free of charge. All were examined clinically and serologically for LAV/HTLV-III infection. Ninety-seven percent were males; 490 (68%) and 198 (28%) described themselves as homosexual or bisexual respectively. This study presents epidemiological data on that group. As in other studies, we found a relationship between anti-LAV/HTLV-III and male homosexual promiscuity, i.e. trends towards higher antibody prevalences, the higher the number of different sexual partners annually and the number of previous sexually transmissible diseases. The occurrence of 18 percent seropositivity in a group with no previous sexually transmissible disease indicate a dissemination of the infection to a subpopulation of Danish homosexuals with a nonpromiscuous lifestyle. Night sweats and lymph node enlargement as subjective complaints along with lymphadenopathy and anal pathology on objective examination were significantly (p less than 0.025) related to positive LAV/HTLV-III serology. Fifty-one percent (337 persons) had neither subjective symptoms nor objective signs, and 50 of these (28% of this asymptomatic group) were seropositive. At this stage of the AIDS epidemic, it is important for surveillance purposes that anti-LAV/HTLV-III testing is made available to all members of risk groups. The establishment of the screening clinics with unconditional attendance and ensured anonymity seems to be an important step in this effort.
PubMed ID
3780322 View in PubMed
Less detail

13 records – page 1 of 2.